Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-05-25

Clinical Trial Update: Hyperbaric Oxygen Therapy for Optic Neuropathies [NA]

View source ↗

Summary

A Stanford-led clinical trial is evaluating hyperbaric oxygen therapy for optic neuropathies, including glaucoma, and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Stanford University | Conditions: Optic Neuropathy, Glaucoma | NA | Status: RECRUITING